2 hours ago
Artelo Biosciences (ARTL) Soars 40% After Securing Fully-Funded Glaucoma Trial Partnership
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
The post Artelo Biosciences (ARTL) Soars 40% After Securing Fully-Funded Glaucoma Trial Partnership appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
5 Undervalued AI Stocks Flying Under Wall Street’s Radar
- 1 hour ago
BMW (BAMXF) Stock — Electric i3 Debuts With 440-Mile Range to Challenge Tesla
- 1 hour ago
Kraken Postpones Stock Market Debut Amid Crypto Market Downturn
- 1 hour ago
X Platform Experiences Major Outage Affecting Thousands of American Users
- 2 hours ago
Tesla (TSLA) vs BYD (BYDDY): Which Electric Vehicle Stock Is the Smarter Buy?